Tempus Launches Open-Source Digital Pathology Consortium with Major Medical Centers
The initiative aims to standardize digital pathology through an open-source platform and image management system.
Category: Company News
Company News
Latest
Company News
Latest
Co-Diagnostics Develops Strategy for Ebola Bundibugyo Virus Assay
Co-Diagnostics has completed its assay development strategy for Bundibugyo virus, following the WHO’s emergency declaration and CDC’s updated traveler screening measures amid ongoing Ebola outbreaks in the DRC and Uganda.
Company News
Latest
Medicare Expands Coverage for Cancer Immunotherapy Monitoring Test
CMS has expanded Medicare coverage for Personalis’ NeXT Personal MRD test, now allowing immunotherapy monitoring in late-stage solid tumor patients, supported by recent clinical evidence from Vall d’Hebron Institute of Oncology.
Bio-Rad Expands Antibody Labeling Kits for Flow Cytometry and Western Blot
Bio-Rad has expanded its TrailBlazer StarBright Dye Label Kits to 32 options, now available in Europe for flow cytometry and fluorescent western blot applications, according to the company.
Read More
Synergen Health Launches New Revenue Cycle Management Solution for Laboratories
Synergen Health has introduced IGNITE, an AI-driven revenue cycle management platform for laboratories, aiming to streamline billing and reduce claim denials through automated processes and specialized RCM teams, according to the company.
Read More
Avant Genomics Raises $3M for Automated Liquid Biopsy Sample Preparation
Avant Genomics has secured over $3 million in funding to develop its Avant Source platform, which aims to automate liquid biopsy sample preparation and improve cell-free DNA recovery.
Read More
Labcorp and Epic Expand Collaboration for Lab Test Ordering
Labcorp’s full test menu is now integrated into Epic’s Aura platform, streamlining lab test ordering and results for health systems and reducing IT complexity.
Read More
NeuroVision Acquires Durin Life Sciences for Neurodegenerative Disease Diagnostics
NeuroVision Imaging has acquired Durin Life Sciences, combining blood-based biomarker tests with retinal imaging and telehealth to advance early detection of Alzheimer’s and Parkinson’s diseases.
Read More
Fujirebio Receives CE Mark for New Alzheimer’s Disease Plasma Assay
Fujirebio Europe has received CE marking for its automated Lumipulse G pTau 217 Plasma assay, designed to help identify amyloid pathology in patients with cognitive decline, according to the company.
Read More
Foundation Medicine Expands Bristol Myers Squibb Deal to Develop MTAP Biomarker Test
Foundation Medicine and Bristol Myers Squibb have expanded their partnership to develop an NGS-based companion diagnostic for identifying homozygous MTAP deletions, supporting targeted therapy development in precision oncology.
Read More
Cyted Health US Laboratory Earns CAP Accreditation
The gastrointestinal molecular diagnostics company’s facility adds College of American Pathologists accreditation to its existing CLIA certification.
Read More
GRAIL to Present New Data on Multi-Cancer Early Detection Test
Presentations will feature results from the NHS-Galleri and PATHFINDER 2 studies involving more than 174,000 participants.
Read More
Illumina Partners with Florida State University Lab for Rare Disease Genome Sequencing
Illumina will provide clinical sequencing services to Florida State University’s new Diagnostic Lab for Pediatric Rare Diseases, aiming to accelerate rare disease diagnostics for an estimated 30 million affected Americans.
Read More
Invivoscribe Launches Automated System Integrating Nucleic Acid Extraction and Quantification
Invivoscribe, in collaboration with Hitachi High-Tech, has launched the PrepQuant System, an automated platform that integrates nucleic acid extraction, concentration, and quantification to streamline molecular testing workflows.
Read More
Fast Sepsis Diagnostics Could Save 36,000 Lives Annually in the US
Early use of rapid sepsis diagnostics could prevent 36,200 deaths and 84,400 sepsis cases annually in the US, according to a multi-country health economic analysis announced by bioMérieux and conducted by the Office of Health Economics.
Read More
New Partnership Aims to Improve Early Alzheimer’s Disease Detection
Circular Genomics and Vitazi.ai have formed a partnership to combine AI-driven retinal imaging and blood-based RNA biomarkers for early Alzheimer’s disease detection, aiming to address gaps in early-stage patient identification.
Read More
ClearNote Health to Present Pancreatic Cancer Test Data at DDW 2026
ClearNote Health will present data at DDW 2026 showing its Avantect Pancreatic Cancer Test achieved 82.6% sensitivity and 97.5% specificity in patients at elevated risk.
Read More
CareDx to Acquire Oncology Diagnostics Company Naveris for $160 Million
CareDx will acquire Naveris for $160 million, adding a Medicare-reimbursed liquid biopsy platform for viral-mediated cancer monitoring to its precision medicine portfolio.
Read More